Fortis Capital Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.35M Buy
11,082
+133
+1% +$35.3K 0.6% 30
2026
Q1
$1.2M Sell
10,949
-7,207
-40% -$1.03M 0.16% 106
2025
Q4
$3.02M Buy
18,156
+7,537
+71% +$1.26M 0.45% 34
2025
Q3
$2.08M Sell
10,619
-17
-0.2% -$2.79K 0.33% 45
2025
Q2
$962K Buy
+10,636
New +$840K 0.17% 93

Other funds holding ALAB

Fortis Capital Advisors's ALAB Position: Q2 2026 in Review

Fortis Capital Advisors increased its Astera Labs (ALAB) stake by 1.2% in Q2 2026, buying an estimated $35.3K and bringing the position to 11,082 shares worth $5.35M. The position accounts for 0.6% of the portfolio, ranked #30.

Fortis Capital Advisors first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Fortis Capital Advisors held 11,082 shares of Astera Labs worth $5.35M as of Q2 2026.
  • Fortis Capital Advisors bought 133 Astera Labs shares in Q2 2026, an estimated $35.3K.
  • Astera Labs made up 0.6% of Fortis Capital Advisors's portfolio in Q2 2026, its #30 holding.
  • Fortis Capital Advisors first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.